Prudential Financial
SLDB icon

Prudential Financial’s Solid Biosciences SLDB Stock Holding History

Prudential Financial’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,990
Closed -$376K – 2420
2025
Q3 		$376K Buy
+60,990
New +$357K ﹤0.01% 2036
2025
Q1 		– Sell
-109,105
Closed -$436K – 2371
2024
Q4 		$436K Buy
109,105
+45,400
+71% +$249K ﹤0.01% 1886
2024
Q3 		$444K Buy
+63,705
New +$517K ﹤0.01% 2260
2022
Q4 		– Sell
-3,080
Closed -$22K – 2692
2022
Q3 		$22K Hold
3,080
– – ﹤0.01% 2626
2022
Q2 		$28K Buy
+3,080
New +$32K ﹤0.01% 2628
2021
Q4 		– Sell
-698
Closed -$25K – 2693
2021
Q3 		$25K Buy
+698
New +$29.6K ﹤0.01% 2574

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential Financial's SLDB Position: Q4 2025 in Review

Prudential Financial sold out of Solid Biosciences (SLDB) in Q4 2025, closing a stake of 60,990 shares — an estimated $376K sold.

Prudential Financial first reported a position in SLDB in Q3 2021 and held it in 6 quarters. The position peaked at $444K in Q3 2024. 130 funds tracked by Wall St. Rank hold SLDB as of Q4 2025.

  • Prudential Financial reported no remaining Solid Biosciences position as of Q4 2025 after selling out during the quarter.
  • Prudential Financial sold 60,990 Solid Biosciences shares in Q4 2025, an estimated $376K.
  • Prudential Financial first reported a position in Solid Biosciences in Q3 2021 and held it in 6 quarters.
  • Prudential Financial's Solid Biosciences position peaked at $444K in Q3 2024.
  • 130 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2025.

Based on Prudential Financial's 13F filing for Q4 2025, filed 13 Feb 2026.